Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8activity
Zb. You et al., Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8activity, J BIOL CHEM, 276(28), 2001, pp. 26398-26404
Activation of the transcription factor nuclear factor-kappaB (NF-kappaB) ha
s been found to play an essential role in the inhibition of tumor necrosis
factor (TNF)-mediated apoptosis, NF-kappaB regulates several antiapoptotic
molecules including inhibitors of apoptosis, Bcl-2 family proteins (A1 and
Bcl-X-L) and IEX-IL. Here we report that the expression of a small death ef
fector domain (DEI)-containing protein, NDED (NF-kappaB-inducible DED-conta
ining protein), depends on the activation of NF-kappaB, The inhibition of N
F-kappaB by IKB alpha a natural inhibitor of NF-kappaB, suppressed NDED mRN
A expression induced by TNF, The restoration of NDED in NF-kappaB null cell
s inhibited TNF-induced apoptosis, Intriguingly, unlike the caspase-8 inhib
itor cellular FADD-like interleukin-1 beta converting enzyme-inhibitory pro
tein (c-FLIP), NDED suppressed TNF-mediated apoptosis by inhibiting TNF-ind
uced caspase-8 enzymatic activity but not the processing of caspase-8, Furt
hermore, NDED could not inhibit etoposide-mediated apoptosis that is indepe
ndent of caspase-8 activation. Our results provide the first demonstration
that NF-kappaB transcriptionally induces the DED-containing protein to supp
ress TNF-mediated apoptosis by inhibiting caspase-8 activity, which offers
new insight into the antiapoptotic mechanism of NF-kappaB.